Cannabis Avicanna and Medipharm Labs expand partnership for self-emulsifying cannabinoid capsules Avicanna's SEDDS technology capsules are designed for enhanced and rapid absorption of cannabinoids Natalia Buendia CalvilloJune 27, 2023
Business MediPharm Labs reports 10% drop in Q2 revenue to $4.3M Toronto-based MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) had a revenue decrease of 10 per cent during its last quarter. On Monday,... Natalia Buendia CalvilloAugust 15, 2022
Business MediPharm Labs sells Australian facility for $6.2M In July last year, the company received a pharmaceutical Drug Establishment License from Health Canada Natalia Buendia CalvilloJuly 12, 2022
Business Medipharm reports 65% net loss decrease in Q1 The company also reported a 14 per cent decrease in revenue Natalia Buendia CalvilloMay 16, 2022